telehealth glp-1 crackdown news FDA issued 25 warning letters to companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FEDS CRACK DOWN ON TELEHEALTH

In addition, according to the FDA, poor compounding practices can result in serious drug quality problems, such as contamination or a drug that contains too much active ingredient

What are GLPS? And what are the benefits

A product may demonstrate: Better stability in a laboratory Higher blood levels after a dose Increased glutathione in selected cells Changes in an oxidative-stress biomarker Those findings can be meaningful, but they do not automatically prove that the product: Improves energy or cognition Prevents cardiovascular or neurodegenerative disease Detoxifies the body in a clinically meaningful way Treats chronic illness Slows biological aging Improves longevity Those larger claims require controlled clinical trials measuring patient-important outcomes

Citrulline malate is valued for its ability to enhance nitric oxide production, leading to improved blood flow, muscle pumps, and nutrient delivery during exercise